Cas no 862588-11-2 (Pyraoxystrobin)
Pyraoxystrobin Chemical and Physical Properties
Names and Identifiers
-
- methyl (E)-2-[2-[[5-(4-chlorophenyl)-2-methyl-pyrazol-3-yl]oxymethyl]phenyl]-3-methoxy-prop-2-enoate
- benzeneac<wbr>
- pyraoxystrobin
- T5NNJ A1 CR DG&
- EO1R BYVO1&
- U1O1 &
- &
- E Form
- Pyraoxystrobin
-
- Inchi: 1S/C22H21ClN2O4/c1-25-21(12-20(24-25)15-8-10-17(23)11-9-15)29-13-16-6-4-5-7-18(16)19(14-27-2)22(26)28-3/h4-12,14H,13H2,1-3H3/b19-14+
- InChI Key: URXNNPCNKVAQRA-XMHGGMMESA-N
- SMILES: ClC1C=CC(=CC=1)C1C=C(N(C)N=1)OCC1C=CC=CC=1/C(=C\OC)/C(=O)OC
Computed Properties
- Exact Mass: 412.119
- Monoisotopic Mass: 412.119
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 29
- Rotatable Bond Count: 8
- Complexity: 565
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 1
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 62.6A^2
Experimental Properties
- Density: 1.21
- Boiling Point: 584.6°C at 760 mmHg
- Flash Point: 307.4°C
- Refractive Index: 1.575
Pyraoxystrobin Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | P847015-10mg |
Pyraoxystrobin |
862588-11-2 | 10mg |
$316.00 | 2023-05-17 | ||
| TRC | P847015-25mg |
Pyraoxystrobin |
862588-11-2 | 25mg |
$689.00 | 2023-05-17 | ||
| TRC | P847015-50mg |
Pyraoxystrobin |
862588-11-2 | 50mg |
$1303.00 | 2023-05-17 | ||
| TRC | P847015-100mg |
Pyraoxystrobin |
862588-11-2 | 100mg |
$2463.00 | 2023-05-17 | ||
| Biosynth | MJB58811-1 mg |
Pyraoxystrobin |
862588-11-2 | 1mg |
$110.00 | 2023-01-03 | ||
| Biosynth | MJB58811-5 mg |
Pyraoxystrobin |
862588-11-2 | 5mg |
$357.50 | 2023-01-03 | ||
| Biosynth | MJB58811-10 mg |
Pyraoxystrobin |
862588-11-2 | 10mg |
$572.00 | 2023-01-03 | ||
| Biosynth | MJB58811-25 mg |
Pyraoxystrobin |
862588-11-2 | 25mg |
$1,072.50 | 2023-01-03 | ||
| Biosynth | MJB58811-50 mg |
Pyraoxystrobin |
862588-11-2 | 50mg |
$1,716.00 | 2023-01-03 | ||
| TRC | P847015-250mg |
Pyraoxystrobin |
862588-11-2 | 250mg |
$ 7600.00 | 2023-09-06 |
Pyraoxystrobin Suppliers
Pyraoxystrobin Related Literature
-
Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
-
Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
-
Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
-
Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
Additional information on Pyraoxystrobin
Recent Advances in Pyraoxystrobin (CAS: 862588-11-2) Research: A Comprehensive Review
Pyraoxystrobin (CAS: 862588-11-2) is a novel strobilurin fungicide that has garnered significant attention in the field of agrochemical and biomedical research due to its broad-spectrum antifungal activity and unique mode of action. As a derivative of the natural strobilurin compounds, Pyraoxystrobin inhibits mitochondrial respiration by binding to the Qo site of cytochrome bc1 complex, thereby disrupting energy production in fungal pathogens. This mechanism has made it a promising candidate not only for agricultural applications but also for potential therapeutic uses in human fungal infections.
Recent studies have focused on optimizing the synthesis and formulation of Pyraoxystrobin to enhance its efficacy and environmental safety. A 2023 study published in the Journal of Agricultural and Food Chemistry demonstrated that a new nanoencapsulation technique significantly improved the stability and bioavailability of Pyraoxystrobin, reducing its environmental persistence while maintaining high antifungal activity. This advancement addresses one of the key challenges in strobilurin fungicides—their potential for resistance development in target pathogens.
In the biomedical realm, researchers have explored Pyraoxystrobin's potential as an antifungal agent against drug-resistant Candida species. A preclinical study conducted at the University of California, San Francisco, showed that Pyraoxystrobin exhibited potent activity against fluconazole-resistant Candida auris strains, with an MIC90 value of 0.5 μg/mL. The compound's unique binding mechanism appears to bypass common resistance pathways, making it particularly valuable in the face of growing antifungal resistance.
Structural-activity relationship (SAR) studies have provided deeper insights into Pyraoxystrobin's molecular interactions. X-ray crystallography data revealed that the methoxyimino side chain at position 862588-11-2 plays a crucial role in stabilizing the compound's binding to the cytochrome bc1 complex. This finding, published in Nature Chemical Biology, has guided the development of next-generation derivatives with improved target specificity and reduced off-target effects.
Environmental impact assessments of Pyraoxystrobin have yielded important regulatory insights. A 2024 European Food Safety Authority report highlighted that while the compound shows moderate toxicity to aquatic organisms, its rapid photodegradation and low bioaccumulation potential make it preferable to many conventional fungicides. Ongoing research aims to further reduce its ecological footprint through advanced formulation technologies and application methods.
Looking forward, the most promising development appears to be the combination of Pyraoxystrobin with biological control agents. Recent field trials in China demonstrated that when used in conjunction with certain Trichoderma species, Pyraoxystrobin's efficacy against rice blast disease increased by 40% while application rates could be reduced by 30%. This integrated pest management approach could significantly enhance the sustainability of fungal disease control in agriculture.
In conclusion, Pyraoxystrobin (862588-11-2) represents a significant advancement in antifungal chemistry with applications spanning agriculture and medicine. The compound's unique mechanism of action, coupled with recent improvements in formulation and application strategies, positions it as an important tool in addressing both crop protection challenges and emerging threats from drug-resistant fungal pathogens in clinical settings.
862588-11-2 (Pyraoxystrobin) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)